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Abstract
Plasmodium knowlesi is a newly described zoonosis that causes malaria in the human pop-
ulation that can be severe and fatal. The study of P. knowlesi parasites from human clinical
isolates is relatively new and, in order to obtain maximum information from patient sample
collections, we explored the possibility of generating P. knowlesi genome sequences from
archived clinical isolates. Our patient sample collection consisted of frozen whole blood
samples that contained excessive human DNA contamination and, in that form, were not
suitable for parasite genome sequencing. We developed a method to reduce the amount of
human DNA in the thawed blood samples in preparation for high throughput parasite ge-
nome sequencing using Illumina HiSeq and MiSeq sequencing platforms. Seven of fifteen
samples processed had sufficiently pure P. knowlesi DNA for whole genome sequencing.
The reads were mapped to the P. knowlesiH strain reference genome and an average map-
ping of 90% was obtained. Genes with low coverage were removed leaving 4623 genes for
subsequent analyses. Previously we identified a DNA sequence dimorphism on a small
fragment of the P. knowlesi normocyte binding protein xa gene on chromosome 14. We
used the genome data to assemble full-length Pknbpxa sequences and discovered that the
dimorphism extended along the gene. An in-house algorithm was developed to detect SNP
sites co-associating with the dimorphism. More than half of the P. knowlesi genome was di-
morphic, involving genes on all chromosomes and suggesting that two distinct types of
P. knowlesi infect the human population in Sarawak, Malaysian Borneo. We use P. knowlesi
clinical samples to demonstrate that Plasmodium DNA from archived patient samples can
produce high quality genome data. We show that analyses, of even small numbers of diffi-
cult clinical malaria isolates, can generate comprehensive genomic information that will im-
prove our understanding of malaria parasite diversity and pathobiology.
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Introduction
Plasmodium knowlesi is a malaria parasite of old world macaques that causes zoonotic malaria
in humans [1]. P. knowlesi has been widely used as an experimental model leading to seminal
discoveries in aspects of malaria biology, including antigenic variation, vaccine development
and erythrocyte invasion (for example [2,3,4]). More recently, the discovery of severe cases of
P. knowlesimalaria in the human population has re-kindled human-disease focussed research
on this important parasite [5]. P. knowlesi lacks unique morphological characteristics and
human infections are often mis-diagnosed as P.malariae or other Plasmodium species[6].
Novel P. knowlesi-specific PCR assays now allow accurate identification of P. knowlesimalaria
and PCR-confirmed cases are continuously reported across Southeast Asia, including severe
and fatal cases in Malaysia [7,8,9,10].
P. knowlesi is a widespread human infectious agent in Southeast Asia, yet we currently
know very little about naturally circulating parasite populations that enter the human host or
the factors that are associated with severe disease. In Sarawak, Malaysian Borneo, we found
that P. knowlesi parasitaemia is associated with disease severity [8,9]. To study the relationship
between parasitaemia and variation in the proteins that are involved in invasion of human
erythrocytes, short regions of two P. knowlesi invasion genes, P. knowlesi normocyte binding
protein (Pknbp) xa and Pknbpxb, were sequenced from more than 100 human infections [11].
Both gene fragments were polymorphic and the Pknbpxa fragment was dimorphic with distinct
co-associating polymorphisms that segregated into two clusters. In the study cohort, patients
were infected with parasites with either Pknbpxa dimorphic type at almost equal frequency but
only alleles found in one dimorphic type associated with markers of disease severity [11].
While this suggests a potential link between invasion phenotypes, parasitaemia and virulence,
it is critical to extend the study beyond a candidate gene level and out to the whole genome.
A reference P. knowlesi genome sequence has been generated from the macaque-adapted ex-
perimental H strain [12], but P. knowlesi genome sequences from clinically well-characterised
isolates are not currently available. The generation of parasite genome sequences from clinical
Plasmodium samples requires a leucocyte depletion step to minimise the amount of contami-
nating human DNA. However, many archived sample collections exist, including our own col-
lection of frozen whole blood samples from patients with P. knowlesimalaria, that have not
been leucocyte depleted before freezing. Adapting depletion approaches to these frozen sample
sets would unlock a wealth of genomic information.
Here we report a method to deplete human DNA from frozen clinical malaria samples and
render them suitable for whole genome sequencing. The method exploits two assumptions; 1)
that not all leucocytes are lysed when whole blood goes through one freeze/thaw cycle and 2)
the more robust parasites would survive the same treatment either in intact infected red blood
cells (IRBCs) or as free parasites released from lysed erythrocytes. We developed a simple filtra-
tion method to remove leucocytes and recover parasite-rich pellets for Plasmodium genome se-
quencing. The method offers the malaria research community a means to interrogate
Plasmodium species genome data in important archived sample collections. In this case, we use
the approach to generate genome sequence data from six previously frozen P. knowlesi clinical
isolates, and show that the Pknbpxa dimorphism may extend across the P. knowlesi genome.
Materials and Methods
Patient samples
Archived frozen whole blood samples were used from adult patients recruited into a non-inter-
ventional study with informed signed consent that included use of samples in related studies.
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Human DNA depletion using Whatman filter paper
EDTA blood samples from P. knowlesi patients were collected and stored at -40°C. The samples
were thawed and the volume measured before gentle mixing in ice-cold PBS at a ratio of 300ul
thawed blood per 5ml cold PBS. The mixture was pipetted into a 10mL syringe barrel, the base
was lined with 3 layers of Whatman No 3 (6uM pore size) to remove small lymphocytes and 3
layers of Whatman No 1 (11uM pore size) on top to remove larger surviving leucocytes. The
filter papers were cut to fit the internal diameter of the syringe and pre-wet with PBS before
use. Not more than 10mL of diluted blood was loaded per syringe column. The filtrate was col-
lected into sterile 50mL centrifuge tubes following centrifugation at 125g for 2 minutes at 4°C.
The columns were washed through with 10mL volumes of cold PBS and each wash was collect-
ed into the filtrate tube by centrifugation as above until the filters were no longer blood-stained.
The total combined filtrate, up to 40 mL, was centrifuged at 2000g for 10 minutes at 4°C to pel-
let any surviving IRBCs and free parasites. Pellets were re-suspended in 1ml cold PBS and
transferred to 1.5ml Eppendorf tubes and recovered by centrifugation at 14,000g, for 2 minutes
at 4°C. Pellets were re-suspended and washed in 1mL cold PBS and collected by centrifugation
as described. This wash step was repeated two more times. The washed IRBC/parasite pellets
were suspended in 20ul Proteinase K (QIAGEN) followed by 200ul cold PBS. The mixture was
vortexed thoroughly before DNA extraction using QIAamp Blood Mini kit (QIAGEN) with
RNase A, as per manufacturers instructions. For samples with more than 100,000 parasites /ul
blood the initial blood dilution step was 150ul thawed blood into 5mL cold PBS.
TaqMan qPCRmultiplexed for human and P. knowlesi DNA
Plasmodium specific 18ssURNA Plasmo1: 50 GTTAAGGGAGTGAAGACGA TCAGA and Plasmo 2:
50 AACCCAAAGACTTTGATTTC TCATAA primers were used [13] with the published P. know-
lesi TaqMan probe 50 CTCTCCGGAGATTAGAACTCTTAGATTGCT labelled with 5'FAM and
3'BHQ1 [14]. Human DNA primers: Plat1-A 50 CTTACCACATCCGCTCCATC, and Plat1-B 50
TTCACACTCTCCGTCACATTG with the probe 50 HEX/CACATCCCC/ZEN/AGTGCCGAGT-
TAGA/3IABkFQ were used. The qPCRmaster mix contained 250nM Plasmo1, 250nM
Plasmo2, 250nM Plat1-A, 250nM Plat1-B, 125nM Pk probe, 125nM Plat1-Probe, 1 x Roche
RT-PCRMaster Mix and 1ul DNA template in 20ul final volume. qPCR cycling was 10 minutes
at 95°C, followed by 45 cycles of 10 seconds at 95°C, 30 seconds at 57°C, and 1 second at 72°C
using the Roche LightCycler 480 II.
Illumina sequencing
DNA was quantified (Qubit Fluorometric Quantitation, Invitrogen, Life Technologies) and
sheared into fragments of 400–600 bp. Illumina libraries were generated using a) the PCR free
protocol (NoPCR) [15] or b) the standard library preparation using the KAPA enzyme [16]
with eight PCR cycles. NoPCR libraries were sequenced on the Illumina HiSeq 2000 platform
for 100 paired-end cycles and standard PCR libraries were sequenced on Illumina MiSeq for
150 paired ends cycles using V4 or V5 SBS sequencing kits and proprietary reagents according
to manufacturer's recommended protocol (https://icom.illumina.com/). Data were analysed
from the Illumina sequencing machines using RTA1.6, RTA1.8 or GA v0.3 analysis pipelines.
P. knowlesiGenome Sequencing Clinical Isolates
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Reference genome
The Plasmodium knowlesi H strain reference genome version 11.1 GeneDB (www.genedb.org/
Homepage/Pknowlesi) was downloaded from PlasmoDB (www.plasmodb.org) [12,17,18]. The
region corresponding to the pknbpxa gene (PKH_146970 and PKH_146980) in chromosome
14 was partially missing and fragmented in the current reference genome and we corrected for
this using the published pknbpxa gene sequence (GenBank accession number EU867791.1) [2].
Common non-coding DNA regions upstream and downstream of the pknbpxa gene were lo-
cated in both the Plasmodium knowlesi strain H reference genome and the published pknbpxa
gene. With this information it was possible to replace the pknbpxa gene (PKH_146970) in the
reference genome sequence with the published EU867791.1 gene sequence without disrupting
subsequent mapping. The pknbpxb gene, which was not annotated correctly, was rectified
using the EU867792.1 published gene sequence [2].
Genome sequence mapping
HiSeq and MiSeq reads from P. knowlesi enriched, human DNA depleted, samples are deposit-
ed in the EMBL-EBI European Nucleotide Archive (http://www.ebi.ac.uk)[19]. The archive ref-
erences are for HiSeq: ERR274221; ERR274222; ERR274224; ERR274225 and MiSeq:
ERR366425 and ERR366426. Sequences mapping to the human genome, representing patient
DNA, were removed from this data in the sequencing pipeline. The reads were mapped to the
corrected P. knowlesi H strain reference genome sequence (PlasmoDB-11.1_PknowlesiH_
Genome.fasta) using Bowtie-2 [20] followed by Bedtools to summarise the coverage of each ge-
nome [21].
Single Nucleotide Polymorphism (SNP) calling
Samtools mpileup with threshold base quality set to 13 was used with BCFtools to generate
Variant Call SNP Format (VCF) files for each P. knowlesi genome sequence [22]. A varFilter
(BCFtools) was applied and all SNP sites with allele frequency less than 0.9 were removed. In-
sertions and deletions were not included in any of the analyses or scripts. Only SNP sites with a
minimum coverage of 13 were taken into consideration.
Linkage Disequilibrium analysis of full-length pknbpxa sequences
extracted from P. knowlesi genome sequence data
We used Artemis [12,17,23,24] and the VCF files to generate full-length pknbpxa gene se-
quences as fasta files from each of the genome sequences (n = 6). The fasta files were converted
to the Haploview compatible PLINK format [25]. Linkage disequilibrium was performed on
the full-length coding region of Pknbpxa sequences using Haploview and analysed using de-
fault parameters [26,27]. Nucleotide diversity (π) was calculated using a 400bp window length
with a step size of 25bp, DnaSP [28].
Identification of polymorphisms genome-wide co-associating with the
Pknbpxa fragment dimorphism
An algorithm was developed to identify SNP sites in each genome sequence (n = 6), co-
associating with the P. knowlesi Pknbpxa dimorphic pattern already identified in a small frag-
ment of this gene [11] and also visible in Artemis on chromosome 14 at the Pknbpxa locus
(Fig. 1). Briefly the script was designed to screen VCF files to identify each SNP and test if the
SNP co-associated with SNPs defining the Pknbpxa dimorphism. Co-associating patterns were
predefined in the algorithm to describe which kind of symbols (SNP pattern) each genome
P. knowlesiGenome Sequencing Clinical Isolates
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required to fit within either of the P. knowlesi Pknbpxa dimorphic forms. Every time a SNP fit
the pattern the event was signalled (recorded). Finally, an image was created to show the densi-
ty of all SNP sites and then the co-associating SNPs for each chromosome (S1 Fig.).
Testing the distribution of co-associated SNPs defined in the Pknbpxa
dimorphism
To identify positions on each P. knowlesi chromosome where the density of co-associating sites
was more evident a Chi square test of independence was applied followed by a calculation of
adjusted residuals. For this, each chromosome was divided into 30 equal parts and a contingen-
cy table was created to reflect the number of SNPs co-associating with the Pknbpxa dimor-
phism per part per chromosome. Adjusted residuals were calculated in a contingency table and
a threshold of> 3.00 for more co-associating SNPs than expected and< -3.00 for less co-asso-
ciating dimorphic SNPs than expected was applied to the resulting values. By applying these
thresholds it was possible to identify, within 99.7% limits of confidence, co-associating SNP
sites for each chromosome with higher or lower than expected co-associating SNP density.
Gene Ontology (GO)
P. knowlesi genes were analysed using Blast2GO http://www.blast2go.com version 2.7.2 [29].
All genes with complete coverage (4623) were blasted against nr@ncbi database and an Inter-
ProScan 5 analysis was performed [30]. The Gene Ontology classification was done with de-
fault parameters [31]. Genes with no (0) co-associating SNP sites, with>0–<10 (1–9) and>9
( 10) SNPs that co-associated with the P. knowlesi genome-wide dimorphism were identified
within each resulting GO group.
Testing for enrichment of dimorphic genes in particular GO subgroups
Genes with dimorphic SNP sites were tested for statistically significant enrichment of dimor-
phic genes in GO subgroups using topGO Enrichment analysis for Gene Ontology. R package
version 2.14.0. Adrian Alexa and Jorg Rahnenfuhrer (2010). (http://www.bioconductor.org/
packages/release/bioc/html/topGO.html). For this we selected two groups of genes those with
one or more dimorphic SNP sites (1) and a separate group with ten or more dimorphic SNP
sites (10) and analysed for enrichment against all genes with at least one SNP whether or
not dimorphic.
Results
Human DNA depletion from frozen whole blood samples
Frozen whole blood samples from fifteen P. knowlesi patients, with parasite counts ranging
from 10,000–400,000 parasite/ul, were thawed and human DNA depleted using an in-house
Fig 1. A screen shot of Artemis DNA view comparing six Plasmodium knowlesi genome sequences from patient isolates to the Plasmodium
knowlesiH strain reference genome sequence. The P. knowlesi normocyte binding protein xa locus on chromosome 14 is shown. The screen shot shows
segregation of the sequences from patient isolates into two groups, (n = 3 in each group) and the dimorphism is clearly visible.
doi:10.1371/journal.pone.0121303.g001
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method. Briefly white blood cells were removed by filtration through Whatman filter paper fol-
lowed by parasite recovery as described in detail (see Methods section). Total human and para-
site DNA was quantified using qPCR (Table 1). Nine of fifteen isolates had the required
>100ng of P. knowlesi DNA, and seven of the nine had<80% human DNA contamination,
the cut-off for Plasmodium genome sequencing, and were suitable for sequencing (Table 1).
Five and two DNA samples were used to generate NoPCR and PCR sequencing libraries and
multiplexed in a single lane on Illumina HiSeq and MiSeq platforms respectively (Table 1). The
remaining six samples had insufficient P. knowlesi DNA and/or>80% human DNA (hDNA)
contamination (Table 1).
DNA obtained from frozen P. knowlesi clinical isolates generated high
coverage genome sequence
P. knowlesi sequence data was generated from seven patient isolates, five from HiSeq runs and
two fromMiSeq runs. The HiSeq runs generated>36 million reads and MiSeq>5 million
reads. An average mapping of>90% was obtained for both HiSeq and MiSeq data producing
Table 1. Clinical samples human DNA depleted using theWhatman filtration method.
Sample ID Parasites/ul Accession ID§ Total hDNA (ng) qPCR Total Pk DNA (ng) qPCR % Pk DNA
47 128,500 ND 302 294 49.3
Duplicate ERR366425* 131 238 64.5
87 47,000 NS 225 51 18.7
Duplicate NS 6 8 56
73 40,000 ERR366426* 33 233 87.6
Duplicate ND 106 162 60.4
91 29,000 NS 269 37 12
220 10,000 NS 735 24 3.1
48 86,000 ND 1402 1167 45.4
Duplicate ERR274221** 421 824 65.7
50A 139,000 ERR274222** 317 2775 89.8
Duplicate ND 415 3280 88.8
50B 390,000 ERR274223 597 1239 67.5
55 186,500 NS 1235 428 25.7
Duplicate NS 3418 433 11.2
58 149,000 ERR274224** 336 506 60
62 139,000 NS 988 71 6.7
178 104,000 NS 103 11 9.4
233 326,000 NS 1015 313 23.5
258 58,000 NS 560 94 14.3
Duplicate NS 245 59 19.4
299 66,000 ERR274225** 626 984 61.1
Samples sequenced using Illumina HiSeq or MiSeq sequencing platforms are labelled. The amount of Parasite DNA recovered and per cent human DNA
contamination are given.
*MiSeq.
**HiSeq.
NS = Not suitable.
ND = Duplicate sample suitable but not sequenced.
§ Accession number EMBL-EBI European Nucleotide Archive (http://www.ebi.ac.uk).
doi:10.1371/journal.pone.0121303.t001
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an average coverage of>140x for HiSeq and>30x for MiSeq. The total number of reads
mapped and not mapped, percent human DNA contamination and coverage per genome se-
quence are summarized in Table 2.
P. knowlesi genome analysis
The reads were mapped to the P. knowlesiH strain reference genome following correction of
the Pknbpxa locus (see materials and methods section). Two genome sequences (ERR274222
and ERR274223) were generated from a single patient representing pre- and post-treatment
samples. Only the pre-treatment sample sequence, ERR274222, was included in subsequent
analyses along with sequences from five other patients all collected pre-treatment.
The sequences covered 5228 genes, including genes and gene fragments annotated as genes
of un-known function. Data from 605 genes were excluded because coverage was zero at one or
more base position leaving 4623 genes in subsequent analyses. This filter excluded all but five
of the 195 SICAVar genes and gene fragments and all but three of the 67 KIR genes and gene
fragments. Both of these gene families are highly polymorphic, and the gene sequences in these
contemporary clinical isolates are likely to be very different to those in the historical monkey-
adapted reference genome, so mapping issues and low coverage in these gene sets is to be ex-
pected. Of the remaining genes 2180 (47.2%) were annotated as genes with unknown function.
The SNP distribution across the genome is shown in S1 Fig.
Dimorphism extends across and beyond Pknbpxa
In a previous study we identified a DNA sequence dimorphism in a fragment (885bp) repre-
senting 10% of the P. knowlesi normocyte binding protein (Pknbp)xa gene that codes for a pro-
tein involved in red blood cell invasion. To determine the extent of the dimorphism across the
gene, full-length Pknbpxa, (PKH_146970) coding sequences were assembled from the six ge-
nome sequences obtained from the same patient cohort. Ninety-one (91) Pknbpxa SNPs co-as-
sociated with the dimorphic pattern (r2 = 1). This dimorphism effectively divides the Pknbpxa
gene sequences into two clusters of sequence types, with Pknbpxa sequences from three
Table 2. P. knowlesi clinical isolate genome sequence summary report.
Sequence ID ERR366426 ERR366425 ERR274221 ERR274223 ERR274222 ERR274225 ERR274224
Technology MiSeq MiSeq HiSeq HiSeq HiSeq HiSeq HiSeq
Sample Ref. SKS-047 SKS-073 SKS-048 SKS-050B SKS-050A SKS-299 SKS-058
Total Reads 6003990 6130562 45217760 47211338 58756176 51769792 41469862
Total Reads Mapped 4731148 5049125 37095534 38967367 48466910 43203711 34547072
Total Reads Not Mapped 1272842 1081437 8122226 8243971 10289266 8566081 6922790
% Reads Not Mapped 21 17 17 17 17 16 16
% Human DNA 1.58 1.59 0.75 0.48 0.14 0.71 0.73
Coverage 32 34 166 175 218 195 156
Number of SNPs 267055 260888 318427 317051 317072 304641 304147
Number Dimorphic SNPs 42771 42771 42771 42771 42771 42771 42771
% Zero Coverage (%) 7.8 7.9 5.5 5.8 5.8 5.9 6
Coverage >1 (%) 91.6 91.4 94.1 93.9 93.9 93.7 93.6
Coverage >5 (%) 90.1 89.9 93.5 93.3 93.4 93.1 92.9
Coverage >10 (%) 88.4 88.4 92.9 92.8 93 92.6 92.4
Genome Size 23487363
doi:10.1371/journal.pone.0121303.t002
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genomes falling into cluster 1 and three into cluster 2. Nucleotide diversity (π) was higher
across the clusters (π = 0.01441), than it was within each cluster, (π = 0.00518 for cluster 1
(n = 3) and π = 0.00868 for cluster 2; n = 3 each). Cluster 1 was less diverse than cluster 2, con-
sistent with Pknbpxa nucleotide diversity found in the previous study, but the significance of
this difference cannot be estimated based on six sequences.
The P. knowlesi genome sequences from clinical isolates were viewed in Artemis, a genome
browser and annotation tool and referenced to the P. knowesi H strain genome sequence. Two
SNP patterns emerged and the Pknbpxa dimorphism was clearly visible with sequences from
three patient isolates clustering into each pattern (Fig. 1). To test whether the dimporphism ex-
tended beyond the boundaries of the Pknbpxa gene, SNP association with the Pknbpxa dimor-
phism was examined first along chromosome 14 and then genome-wide using an in-house
script (see Materials and Methods section). The dimorphic SNP pattern was evident at multiple
genetic loci on all chromosomes (S1 Fig.). The relative distribution of co-associated SNPs on
each chromosome was determined by dividing each chromosome into 30 equal parts and using
the Chi squared test of independence to test expected and observed events (S1 Table). Although
the dimorphism extends across the full genome, the intensity and distribution is not uniform
or clustered in any particular chromosomal region. The position and number of non-synony-
mous and synonymous SNPs co-associating with the dimorphism per gene per chromosome
are represented in Fig. 2.
More than half of the P. knowlesi genes in the genome, 2801 of 4623 genes (60.8%), appear
to be dimorphic. Within the dimorphic group the number of dimorphic SNP sites per gene var-
ied widely. For example, while Pknbpxa had a total of 326 SNPs, of which 91 (27.9%) co-associ-
ated with the dimorphism, a related gene of similar size, Pknbpxb, had a total of 197 SNPs of
which only 5 (2.2%) co-associated with the dimorphism (S2 Table). Applying a more conserva-
tive cut-off identified 507 genes with10 co-associating SNPs, representing 11% of genes in
the genome with adequate coverage. Of these 301 (59.5%) were annotated as genes of unknown
function. The chromosome location and annotated function of the remaining 206 genes is
listed in S2 Table. Notable genes within this high stringency dimorphic group included 12 of
27 (44%) of genes annotated as transcription factors with AP2 domains in the P. knowlesi ge-
nome. Several genes associated with drug resistance in other Plasmodium species, such as puta-
tive multi drug resistance-associated protein PkMRP1(PKH_144590) and putative multidrug
resistance protein, PkMDR 2 (PKH_125840) S2 Table, were also dimorphic, while the putative
chloroquine resistance transporter (CRT) gene (PKH_010710) had 23 SNPs, none were dimor-
phic and only one SNP conferred an amino acid change.
The enrichment of dimorphic genes among genes encoding transcription factors with AP2
domains was obvious and identified manually. We then used Gene Ontology (GO), (Blast2GO)
tools to examine whether other P. knowlesi dimorphic genes were enriched in GO groups that
served particular biological functions. Genes were sorted into GO term groups and sub-groups
with putative or known molecular function, cellular process activity and biological process ac-
tivity (Table 3). We then calculated the proportion genes with1 dimorphic SNP in each GO
group (Table 3). Most of the GO term groups had, as expected, approximately 60% dimorphic
genes but there was variation (Table 3). If dimorphic genes have evolved randomly over time
then the proportion of genes with dimorphic SNP sites in the GO groups would not be ex-
pected to be different from the distribution of genes with dimorphic SNP sites in the whole ge-
nome that is: 39% of genes with no dimorphic SNPs; 50% of genes with 1–9 dimorphic SNPs
and 11% of gene with ten or more dimorphic SNPs. Several GO sub-groups had more genes
than expected with 1–9 dimorphic SNP sites and10 dimorphic SNP sites for example genes
with molecular transducer activity, nucleic acid binding transcription factor activity and mem-
brane association (Fig. 3a, 3b and 3c). There were also sub-groups of genes where dimorphic
P. knowlesiGenome Sequencing Clinical Isolates
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SNP sites were under-represented, including structural and molecular activity, developmental
process and immune system process (Table 3 and Fig. 3). We used topGO to test for statistically
significant enrichment of dimorphic genes in GO term groups (Table 4). In the first instance
all genes with at least one dimorphic SNP were analysed and there was significant enrichment,
particularly in the ion binding function, helicase activity and tRNA metabolic process function
GO term groups (Table 4). Genes with10 dimorphic SNPs were significantly enriched in the
nucleic acid binding transcription factor activity and kinase activity GO term groups (Table 4).
Discussion
Here we describe a method for enriching Plasmodium DNA from frozen whole blood samples
collected from patients with malaria. The method required at least 200ul of whole blood at
>40,000 parasites/ul to obtain sufficient parasite DNA for genome sequencing platforms. Para-
site DNA recovery was inconsistent and human DNA contamination was the main problem.
Nonetheless, seven of fifteen patient samples had sufficiently enriched P. knowlesi DNA to pro-
duce high quality genome sequences using Illumina sequencing platforms. The success may in
Fig 2. The number and position of SNP sites per gene co-associating with the P. knowelsi genome-wide dimorphism. Non-synonymous
polymorphisms (red) are shown above the line and synonymous polymorphisms (blue) are shown below the line. The line is drawn at zero. The
chromosomes are drawn to scale and the height of the bars represents the number of SNP sites per gene per region of each chromosome. The scale is given
in the boxed area and is the number of SNP sites per gene.
doi:10.1371/journal.pone.0121303.g002
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part be because P. knowlesi is less AT rich (62%) than other Plasmodium genomes [12] perhaps
reducing amplification bias. Combining the frozen sample filtration method described here
with methylated DNA digestion and target enriched sequencing approaches described by oth-
ers [16,32], may yield valuable Plasmodium genome data from many precious pre-existing fro-
zen clinical sample collections.
In a previous study we identified a sequence dimorphism in a fragment (885bp) of the P.
knowlesi normocyte binding protein (Pknbp)xa that codes for a protein involved in red blood
cell invasion [11]. Pknbpxa dimorphic cluster 2 contained alleles associated with markers of
disease severity implying that dimorphic cluster 2 may contain more virulent parasites than
cluster 1. Our genome data revealed that the dimorphism extended along the full-length
(>8000bp) Pknbpxa coding region, along chromosome 14 and beyond. SNPs co-associating
with the Pknbpxa dimorphism were distributed genome-wide across all chromosomes.
Table 3. Summary of P. knowlesi gene ontology (GO) analysis and the proportion of genes in each group with dimorphic SNP's.
Gene ontology (GO)
group
GO-ID GO- subgroup Total number of
genes
Total genes in
dimorphism
Proportion in
dimorphism
Molecular function GO:0060089 Molecular transducer activity 5 3 0.60
GO:0000988 Protein binding transcription factor
activity
8 4 0.50
GO:0001071 Nucleic acid binding transcription
factor activity
31 23 0.74
GO:0030234 Enzyme regulator activity 41 24 0.59
GO:0005215 Transporter activity 101 63 0.62
GO:0005198 Structural molecule activity 151 67 0.44
GO:0003824 Catalytic activity 999 653 0.65
GO:0005488 Binding 1031 664 0.64
Cellular Processes GO:0031012 Extracellular matrix 1 0 0.00
GO:0005576 Extracellular region 6 3 0.50
GO:0031974 Membrane-enclosed lumen 55 34 0.62
GO:0016020 Membrane 15 12 0.80
GO:0005623 Cell 1054 573 0.54
GO:0043226 Organelle 813 423 0.52
GO:0032991 Macromolecular complex 447 229 0.51
Biological processes GO:0051704 Multi-organism process 5 4 0.80
GO:0002376 Immune system process 3 1 0.33
GO:0022610 Biological adhesion 4 4 1.00
GO:0032502 Developmental process 8 2 0.25
GO:0040011 Locomotion 10 5 0.50
GO:0000003 Reproduction 7 3 0.43
GO:0023052 Signaling 72 40 0.56
GO:0065007 Biological regulation 109 59 0.54
GO:0071840 Cellular component organization or
biogenesis
184 99 0.54
GO:0050896 Response to stimulus 157 93 0.59
GO:0051179 Localization 255 155 0.61
GO:0044699 Single-organism process 264 149 0.56
GO:0009987 Cellular process 1215 721 0.59
GO:0008152 Metabolic process 1211 716 0.59
Gene Ontology assigned using Blast2GO—Software for Biologists, http://www.blast2go.com.
doi:10.1371/journal.pone.0121303.t003
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Interestingly, even within the limitation that only six samples were sequenced, the dimor-
phism comprised numerous non-synonymous substitutions, suggesting, for the first time, that
there may be at least two distinct types of P. knowlesi circulating in Sarawak, Malaysian Borneo,
and that some may be more virulent that others. Dimorphic loci have been described in many
Plasmodium species, particularly in merozoite surface antigens and invasion ligands of P. fal-
ciparum and P. vivax [33,34,35]. In P. ovale dimorphic characteristics at selected loci prompted
the division of P. ovale into two sub-species [35]. Even so the evolution and maintenance of al-
lelic dimorphisms in Plasmodium species is difficult to explain [34]. Here we demonstrate a ge-
nome-wide dimorphism, involving more than half of the genes in the P. knowlesi genome,
including genes coding for functions that transcend from exposed parasite surfaces to pro-
tected internal sites. The sub-division of P. knowlesi into distinct types will require further se-
quence confirmation, yet the genome-wide nature of the dimorphism is striking.
Fig 3. P. knowlesi genes are grouped by gene ontology (GO) terms. The percent of genes in each GO sub-group of a) molecular function, b) cellular
processes and c) biological processes are shown, n = the total number of mapped annotated genes in each GO sub-group. Percent of genes in GO
subgroups with: no dimorphic SNP sites shown in brown, genes with 1–9 dimorphic SNP sites turquoise and genes with10 dimorphic SNP sites purple.
The expected percent of genes with 1–9 dimorphic SNPs (50%) is marked with a turquoise hatched line and the expected percent of genes with10
dimorphic SNPs (11%) is marked with a purple hatched line. Gene ontology was assigned using Blast2GO—Software for Biologists, http://www.blast2go.
com.
doi:10.1371/journal.pone.0121303.g003
P. knowlesiGenome Sequencing Clinical Isolates
PLOS ONE | DOI:10.1371/journal.pone.0121303 April 1, 2015 11 / 16
Although there was significant enrichment of dimorphic genes in several GO functional
groups it is not clear what is driving a genome-wide dimorphism in P. knowlesi. Interestingly
twelve genes implicated in parasite lifecycle stage-specific transcription, the putative transcrip-
tion factors with Apicomplexan Apetala2 (AP2) domains [36,37,38,39] were dimorphic. Varia-
tion at these loci may mark genetically distinct lifecycle characteristics isolating P. knowlesi
into strains or subspecies. In addition, all nine members of the ABC, ABC C transporter pro-
tein family of genes, annotated in the P. knowlesi genome, were dimorphic [12,40]. These genes
are found in all phyla and represent an ancient gene family that, in eukaryotes, expel a wide
range of unwanted substrates [41]. This family of genes include P. knowlesi PkMDR2 and
PkMRP1 that were both polymorphic and dimorphic implying selection pressure at these loci.
PkMDR2 and PkMRP1 are orthologues of P. falciparum PfMDR 2 and PfMRP1, genes that
carry genetic markers of drug resistance, including resistance to mefloquine [40,42]. Tantaliz-
ingly, experimental lines of P. knowlesi were found innately resistant to mefloquine in Rhesus
monkeys and clinical isolates did not respond well to mefloquine ex vivo [43,44]. Patients with
uncomplicated P. knowlesi infections responded to mefloquine but one patient with severe dis-
ease exhibited RIII type resistance [45,46,47].
Selection at these promiscuous transporter loci in zoonotic parasites that, unlike P. falcipa-
rum, are not under conventional drug selection pressure may at first seem surprising. However,
domestic and wild animals eat plants with bio-active properties—they self-medicate [48]. The
Table 4. topGO gene enrichment analysis.
Gene Ontology (Blast@GO) topGO term functional description topGO ID 1 dimorphic
SNPs
10 dimorphic
SNPs
Molecular Function p = p =
Binding Ion binding GO:0043167 0.000077 0.01011
Catalytic activity Helicase activity GO:0004386 0.000095
Catalytic activity ATPase activity GO:0016887 0.0014 0.02964
Catalytic activity Hydrolase activity, acting on glycosyl
bonds
GO:0016798 0.0328
Catalytic activity DNA binding GO:0003677 0.0121
Catalytic activity GTPase activity GO:0003924 0.0421
Nucleic acid binding transcription factor activity Nucleic acid binding transcription factor
activity
GO:0001071 0.000037
Catalytic activity Kinase activity GO:0016301 0.00067
Cellular Component
Cell; Organelle Microtubule organizing center GO:0005815 0.021
Cell Plasma membrane GO:0005886 0.037
Cell; Organelle Nucleus GO:0005634 0.0029
Cell; Organelle Cytoskeleton GO:0005856 0.0402
Biological Process
Metaboloc process; Cellular process tRNA metabolic process GO:0006399 0.00033
Metaboloc process; Cellular process Cellular amino acid metabolic process GO:0006520 0.00357
Single-organism process; Metaboloc process;
Cellular process
Mitosis GO:0007067 0.00849
Metaboloc process; cellular process Nucleobase-containing compound
catabolic process
GO:0034655 0.01453
Multi-organism process Transport GO:0006810 0.03512
Metaboloc process; cellular process Cellular protein modiﬁcation process GO:0006464 0.03678
Metaboloc process; cellular process Cellular nitrogen compound metabolic
process
GO:0034641 0.028
doi:10.1371/journal.pone.0121303.t004
P. knowlesiGenome Sequencing Clinical Isolates
PLOS ONE | DOI:10.1371/journal.pone.0121303 April 1, 2015 12 / 16
jungles of Sarawak are considered un-mined treasure-troves of plant species with medicinal
properties that are freely available to the animal species living there, including the macaque res-
ervoir of P. knowlesi [49]. Selection at Plasmodium loci, that have evolved to eliminate natural
toxins, then assumes biological relevance. Unfortunately these loci also evolve to eliminate an-
timalarial compounds when used to treat patients with malaria.
P. knowlesi is a relatively 'un-tamed' Plasmodium species, therefore P. knowlesi genomes
may retain ancient and diverse genetic signatures, that are presently invisible in heavily drug
selected human-host restricted parasite populations such as P. falciparum and P. vivax. High
throughput pathogen genome sequencing is a powerful new tool for infectious disease research.
Here we use Illumina HiSeq and MiSeq platforms to produce high quality P. knowlesi genome
sequences from difficult archived frozen samples. Analysis of the sequences uncovered a P.
knowlesi genome-wide dimorphism that suggests there are least two types of P. knowlesi para-
sites in our patient cohort. We further discovered dimorphic genes among transporter genes
that are important in antimalarial drug resistance. Genome-wide pathogen analyses, of even a
small number of clinical malaria isolates, instantly added context to our understanding of Plas-
modium pathobiology, particularly through between-species comparison.
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S1 Fig. P. knowlesi genome SNP density map. Six P. knowlesi genome sequences from patient
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